Shopping Cart
- Remove All
- Your shopping cart is currently empty
JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK, targeting critical pathways in autoimmune diseases. The simultaneous inhibition of the BTK/JAK3 signaling pathway exerts a synergistic effect, making JAK3/BTK-IN-4 a promising therapeutic candidate for JAK3 kinase and/or BTK-related diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 10-14 weeks | |
50 mg | $1,980 | 10-14 weeks | |
100 mg | $2,500 | 10-14 weeks |
Description | JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK, targeting critical pathways in autoimmune diseases. The simultaneous inhibition of the BTK/JAK3 signaling pathway exerts a synergistic effect, making JAK3/BTK-IN-4 a promising therapeutic candidate for JAK3 kinase and/or BTK-related diseases. |
Molecular Weight | 440.93 |
Formula | C21H25ClN8O |
Cas No. | 2673196-38-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.